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Background/Aims: Transforming growth factor beta1 (TGF-β1) is a key cytokine in the production of extracellular matrix. A 
genetic polymorphism at codon 10 of the TGF-β1 gene is associated with liver fibrosis. We investigated the effect of genetic 
polymorphisms at codon 10 on the development of alcoholic liver cirrhosis (ALC). Methods: In total, 119 controls and 182 
patients with ALC, were enrolled in the study. Clinical and laboratory data including total lifetime alcohol intake were collected at 
enrollment. The genotype at codon 10 was determined for each patient by single-strand conformation polymorphism. 
Results: There were three types of genetic polymorphism at codon 10: homozygous proline (P/P), heterozygous proline/leucine 
(P/L), and homozygous leucine (L/L). Among the controls, the proportions of P/P, P/L, and L/L were 26.1%, 44.5%, and 29.4%, 
respectively in the ALC group, these proportions were 23.1%, 43.4%, and 33.5%, respectively. The genotype distribution did not 
differ between the controls and the ALC group. In the ALC group, age, total lifetime alcohol intake, and distribution of Child-Pugh 
class did not differ with the genotype. Of the male patients with ALC (n=164), the proportions of P/P, P/L, and L/L were 20.1%, 
44.5%, and 35.4%, respectively the genotype distribution did not differ between the male controls and the male ALC patients. 
Conclusions: The genotype at codon 10 in TGF-β1 does not appear to influence the development of ALC. Further study is 
needed to investigate other genetic factors that influence the development of ALC in patients with chronic alcohol intake. (Korean 
J Hepatol 2011;17:37-43)
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INTRODUCTION
According to the Korea national health and nutrition 
examination survey conducted by the Korean Center of Disease 
Control in 2008, the monthly alcohol consumption rate (rate of 
alcohol consumption more than once a month) of Korean adults 
older than 19 years is 58.7%, which is slightly lower than 61.5% 
in U.S.A. When it is divided to the male and the female, the 
monthly alcohol consumption rate of the male was 74.8%, which 
is higher than 68.2% in U.S.A. The heavy alcohol consumption 
rate (more than 80 g of alcohol drinking on one occasion or 
drinking more than two times a week) was 20.2%.
1,2
Until now, in Korea, studies on liver damage by alcohol 
consumption have not been conducted in nationwide. 
According to recent studies, 7-31% of chronic liver diseases 
are alcoholic liver diseases.
3,4 Nevertheless, because drink-
ing rates are substantial in chronic hepatitis B and hepatitis C 
patients, more patients than expected may be affected by 
alcohol.
It is well known that alcohol consumption caused 
inflammation in the liver, and furthermore, it induces liver 
fibrosis. Alcohol induces liver fibrosis by the following 
mechanism. First, acetaldehyde which is the metabolite of 
alcohol increases the synthesis of collagen by directly acting 
on hepatic stellate cells, alternately, it increases the synthesis 
of collagen by accelerating the synthesis of transforming 38  The Korean Journal of Hepatology Vol. 17. No. 1, March 2011
growth factor (TGF)-β1 in hepatic stellate cells. Second, 
reactive oxygen species produced in liver cells by alcohol 
metabolism induces the synthesis of collagen in hepatic 
stellate cells. Third, hepatocyte apoptic bodies induced by 
alcohol are phagocytized by Kupffer cells and hepatic 
stellate cells, which activates stellate cells and increases 
TGF-β1.
5,6
However, not all drinkers develop liver fibrosis or 
cirrhosis, and even in heavy drinkers, only approximately 
15-20% cases develop liver fibrosis or cirrhosis.
5 The risk 
factors for cirrhosis are drinking habits, the duration of 
drinking, the content of alcohol, the activity of enzymes 
involved in alcohol metabolism, gender, estrogen, age, the 
presence or absence of associated liver diseases, etc.
5-7 
Among them, as the host factors for the development of 
alcoholic liver fibrosis, the accumulation of acetaldehyde, 
acceleration of oxidative stress, and genetic factors involved 
in the production of inflammatory cytokines have been 
suggested.
5
As described above, TGF-β1 is involved in the mecha-
nism of liver fibrosis induced by alcohol.
8,9 The genetic 
polymorphism of TGF-β1 can effect on the level of its 
production.
10 Therefore, this genetic polymorphism may 
explain the role of host factors for the progression to alcoholic 
liver cirrhosis (ALC) in chronic alcohol drinkers. TGF-β1 
gene is located in chromosome 19q13. Total 7 regions of 
genetic polymorphisms are present: -988, -800 and -509 of 
the promoter region, the nontranslated region +72, codon 10 
and 25 of the signal sequence region, and codon 629 of the 
gene coding region.
11-13 Nonetheless, in Koreans and other 
Asians, the genetic polymorphism was detected only in -509 
and codon 10.
14-16
Among the polymorphic regions of TGF-β1 gene, codon 
10 and 25 of the signal sequence region are involved in 
pulmonary and liver fibrosis, and they are the regions inves-
tigated most extensively.
10,12-14,16 However, there is no genetic 
polymorphism in codon 25 in Korean.
14-16 There is 3 geno-
types at codon 10; nucleotide sequence CCG/CCG that is 
proline homozygote (P/P), CCG/CTG that is proline/leucine 
heterozygote (P/L), and CTG/CTG that is leucine homo-
zygote (L/L).
10,17-19
Therefore, we investigated whether the genotype at codon 




This study was conducted from December 1999 to June 
2001 on 119 subjects who were negative for both hepatitis B 
surface antigen (HBsAg, RIA, General Biologicals Corp, 
Hsin Chu, Taiwan) and anti-hepatitis C virus (anti-HCV, 
RIA, General Biologicals Corp) with normal liver function 
(Control group), and from December 2000 to December 
2002 on 182 ALC patients with the significant drinking 
history and negative for both HBsAg and anti-HCV (Cirrhosis 
group). The definition of cirrhosis was cases satisfying 2 of 
the followings: (1) gastric or esophageal varix in the upper 
gastrointestinal endoscopy, (2) regenerated or cirrhotic 
liver surface, and (3) splenomegaly in abdominal ultra-
sonography or computed tomography. The definition of the 
significant drinking history was that in the male, daily 
alcohol consumption is more than 80 g, more than 5 times 
per week, and more than 10 years of drinking. In the female, 
daily alcohol consumption is more than 40 g, drink more than 
5 times per week, and longer than 10 years of drinking.
20,21
Collection of clinical data and Estimation of
alcohol consumption
The amount of alcohol consumption was measured by in-
dividual history taking. The content of inquiry included the 
average amount of alcohol consumed daily, the frequency of 
drinking per week, and the duration of drinking. Considering 
the inaccuracy of the calculation of the amount of alcohol 
consumption, the total amount of alcohol consumption was 
categorized as follows: less than 500 kg, 500-999 kg, 1,000 
-1,499 kg, and more than 1,500 kg. All clinical data were 
collected at the time of enrollment. The study protocol was 
approved by the institutional review board of Gil Hospital, 
Incheon, Korea.
Examination of the genotype at the codon 10
in TGF-β1 gene
The whole blood sample was collected from all controls 
and patients. The buffy coat was separated and stored frozen 
at -80℃. Genomic DNAs were extracted from peripheral 
blood leukocytes using proteinase K and phenol/chloroform. 
Polymerase chain reaction (PCR) was performed by using a 
primer set (sense 5'-TGT TCG CGC TCT CGG CAG T-3', Jong Joon Lee, et al. Genetic polymorphism in TGF-β1 gene and alcoholic cirrhosis  39
Table 1. Clinical characteristics of the controls and the patients with alcoholic liver cirrhosis (ALC)
Controls (n=119) ALC (n=182) P-value
Age (years) 48±13 57±11 <0.001
*
Sex (M/F) 59/60 164/18 <0.001
†
AST (U/L) 26±10 91±117 <0.001
*
ALT (U/L) 26±8 42±51 <0.001
*
Albumin (g/dl) 4.4±0.3 3.0±0.6 <0.001
*
Total bilirubin (mg/dl) 0.8±0.4 4.6±6.6 <0.001
*
Platelet count (×10
3/μL) 271±64 109±64 <0.001
*
Prothrombin time (seconds) 16.7±3.9
Child-Pugh class (A/B/C) 37/76/69
Data represent mean±SD or number.
* Student’s  t-test, 
† χ
2-test.
ALC, alcoholic liver cirrhosis; ALT, alanine aminotransferase; AST, asparatate aminotransferase; M, male; F, female.
anti-sense 5'-TCA CCA GCT CCA TGT CGA TA-3') that 
amplified the DNA fragment including codon 10. PCR 
mixture consisted of MgCl2 1.5 mM/L, KCl 50 mM/L, Tris-HCl 
10 mM/L, dNTP 200 M/L, primer 0.5 μM/L, Taq polymerase 
1U (Bioneer, Daejeon, Korea), and genomic DNA 50 ng. 
After initial denaturation at 94℃ for 5 minutes, thermocy-
cling consisted of denaturation at 94℃ for 30 seconds, 
annealing at 60℃ for 30 seconds, extension at 72℃ for 30 
seconds for 35 cycles, and followed by a final extension at 
72℃ for 5 minutes. 
For the single stranded conformational polymorphism 
(SSCP) analysis, 2 μL of the PCR product were mixed with 8 
μL of denaturing solution containing formamide, 250 mM 
NaOH, 25 mM EDTA, and 0.05% bromophenol blue. Then 
the DNA samples were denatured at 94℃ for 5 minutes, 
dipped in ice and loaded onto a 13.5% polyacrylamide
 
(acrylamide to bisacrylamide ratio of 29:1) gel. Single- 
stranded DNA migrated through the gel at 40 W power for 6 
hours in a 4℃ cold room and visualized by silver staining. 
The genotypes were determined according to the genotype 
of SSCP used by Yu et al.
22
Statistical analysis
Continuous variables were presented as a mean±standard 
deviation and compared by the Student’s t-test. Categorical 
variables were presented as the frequency (percentage), and 
compared by the χ
2-test. To compare the continuous varia-
bles according to genotypes, ANOVA was used. The χ
2-test 
was used to compare the genotype at the codon 10 between 
the control group and the cirrhosis group.
A  P-value less than 0.05 was considered statistically 
significant. For statistical analysis, the SPSS version 12.0 
(SPSS, Chicago, IL, USA) was used. 
RESULTS
Clinical characteristics of the control group and
the cirrhosis group
The mean age of the control group was 48±13 years and 
the mean age of the cirrhosis group was 57±11 years. The 
ratio of the male and the female of the control group was 
59/60 and the ratio of the male and the female of the 
cirrhosis group was 164/18. The two groups showed significant 
differences in clinical characteristics (Table 1). Twenty four 
patients in the cirrhosis group had hepatocellular carcinoma 
(HCC).
The genetic polymorphism at the codon 10 in
TGF-β1 gene
In the control group, the proportions of P/P, P/L, and L/L 
genotypes were 26.1%, 44.5%, and 29.4%, respectively. In 
the cirrhosis group, the proportions of P/P, P/L, and L/L 
genotypes were 23.1%, 43.4%, and 33.5%, respectively. 
There was no significant difference between the two groups 
(Fig. 1). Because 24 patients with HCC were included, the 
distribution of genotype at codon 10 in the cirrhosis group 
excluding patients with HCC was examined. The proportions 
of P/P, P/L, and L/L genotypes were 23%, 43%, and 34%, 
respectively. There was no significant difference between 
the control group and the cirrhosis group excluding HCC. 40  The Korean Journal of Hepatology Vol. 17. No. 1, March 2011
Table 2. Clinical characteristics of the ALC group according to the genetic polymorphism at codon 10
P/P (n=42) P/L (n=79) L/L (n=61) P-value
Age (years)
* 57±10 56±12 58±10 0.506
†
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  500-999 kg, n (%)
  1,000-1,499 kg, n (%)








































Figure 1. Comparison of genetic polymorphisms at codon 10 
between controls and patients with alcoholic liver cirrhosis 
(ALC). The genotype distribution at codon 10 did not differ 
between controls and ALC patients.
Figure 2. Comparison of genetic polymorphism at codon 10 
between male controls and male patients with ALC. The genotype
distribution at codon 10 did not differ between controls and ALC 
patients.
Since cirrhosis was diagnosed clinically, subgroup analysis 
was performed in overt cirrhotic patients with Child-Pugh 
class B and C. The proportions of P/P, P/L, and L/L geno-
types were 24.1%, 44.1%, and 31.7%, respectively. There 
was no significant difference between the control group and 
the overt cirrhotic patients.
Clinical characteristics of each genotype in the 
cirrhosis group
Age and Child-Pugh class of each genotype in the cir-
rhosis group were not different. In regard to the amount of 
alcohol consumption, not only the total amount but also the 
distribution of the subdivided amount of alcohol consumption 
was not different. Nevertheless, the P/P genotype was 33 
males and 9 females, and in comparison with the P/L genotype 
(male/female: 73/6) and the L/L genotype (male/female: 
58/3), females were more abundant (P=0.015, Table 2).
The distribution of the genotype at codon 10 
in the male cirrhosis group and clinical 
characteristics of each genotype
In the male cirrhosis group (n=164), the proportions of 
P/P, P/L, and L/L genotypes were 20.1%, 44.5%, and 35.4%, 
respectively. There was no significant difference between 
the control group and the male cirrhosis group (Fig. 2). In 
59 males of the control group, the proportions of P/P, P/L, 
and L/L genotypes were 22.0%, 44.1%, and 33.9%, respectively, 
which was not different from the male cirrhosis group. 
When clinical characteristics according to each genotype 
were compared in the male cirrhosis group, age, the amount 
of alcohol consumption, and the distribution of Child-Pugh 
class were not different (Table 3).
P = 0.949Jong Joon Lee, et al. Genetic polymorphism in TGF-β1 gene and alcoholic cirrhosis  41
Table 3. Clinical characteristics of the male ALC patients according to the genetic polymorphism at codon 10
P/P (n=33) P/L (n=73) L/L (n=58) P-value
Age (years)




  <499 kg, n (%)
  500-999 kg, n (%)
  1,000-1,499 kg, n (%)
  ≥1,500 kg, n (%)
1,209±106
4( 1 2 . 1 % )
16 (48.6%)
4( 1 2 . 1 % )





















P/P, proline homozygous genotype; P/L, proline/leucine heterozygous genotype; L/L, leucine homozygous genotype.
DISCUSSION
Whether the genotype at codon 10 in TGF-β1 gene is 
associated with elevated TGF-β1 synthesis and fibrosis is 
controversial. In the L/L genotype, the serum concentration 
of TGF-β1 is higher and pulmonary fibrosis is more accel-
erated than other genotypes.
10 In liver fibrosis induced by 
hepatitis B virus (HBV), the L/L genotype accelerate cirrhosis 
in comparison with other genotypes.
22 Nevertheless, contra-
dictory to this, it has been also reported that in the P/P 
genotype, the serum concentration of TGF-β1 is higher than 
other genotypes,
23-26 and liver fibrosis progresses rapidly in 
the genotype containing proline.
13,26 On the other hand, it 
has been also reported that the genotype at codon 10 is not 
associated with liver fibrosis.
9,12,27,28 It is thought that the 
reason of such results contradictory to each other may be the 
effect of the sample size, races, and the difference of the 
cause of liver diseases such as HBV, hepatitis C virus (HCV), 
and alcohol.
In this study, the distribution of the genotype at codon 10 
in the cirrhosis group was not different from the control 
group. This implies that the genetic polymorphism at codon 
10 does not exert great effects on the development of ALC as 
a host factor. In the study reported by Oliver et al
9 and Bathgate 
et al
29 the development of ALC was not associated with the 
genetic polymorphism at the codon 10, which is con-
sistent with the results of this study. 
 Liver damage induced by alcohol is different according 
to gender. In the female, liver damage induced by alcohol 
appears earlier than the male, and females are more vulner-
able to alcohol toxicity.
7 Because females excrete less 
alcohol dehydrogenase than males and thus the alcohol me-
tabolism rate in the stomach is lower, the rate of the removal 
of alcohol from body is lower and thus the concentration of 
serum alcohol is high, which worsens liver damage.
7,30,31 In 
addition, the female hormone estrogen sensitizes Kupffer 
cells to endotoxin, alcohol enhances the expression of endo-
toxin receptor resulting in the acceleration of the synthesis 
of tumor necrosis factor (TNF), interleukin (IL)-1, IL-6 and 
other proinflammatory cytokines, and induces inflammation 
in the liver.
7 In addition, estrogen exerts effects on the 
expression of cytochrom P450 2E1 (CYP2E1) which is one 
of enzymes of alcohol metabolism.
7 Therefore, males were 
selected from the cirrhosis group, and the genetic poly-
morphism at codon 10 in the cirrhosis group was compared 
with that in the control group. However, even in such analy-
sis, there is no difference between the two groups. 
This may be due to other host factors, in other words, oth-
er genetic polymorphism mediating effects on the activation 
of alcohol dehydrogenase, acetaldehyde dehydrogenase, and 
cytochrome P-450 system involved in alcohol metabolism.
5,6,30 
In addition, the genetic polymorphism of TNF-α or other 
cytokines gene may play more important roles.
5-7,12,28 Additional 
studies on them are required in the future.
Another factor exerting effects on the development of 
ALC is the total amount of alcohol consumption. Generally, 
alcoholic liver diseases are developed in individuals consumed 
more than 80 g alcohol daily for longer than 10 years.
20 In 
females, individuals consumed smaller amounts (more than 
40 g alcohol) daily for longer than 10 years develop alcoholic 
liver diseases.
21 Therefore, in this study, the significant 
alcohol consumption was defined as more than 80 g in the 
male and more than 40 g in the female. In addition, since the 
amount of alcohol consumption was assessed by history 
taking only, considering the inaccuracy of the measurement 
of the amount of alcohol consumption, the amount was 
subdivided. If the amount of alcohol consumption according 
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amount of alcohol consumption is high in particular geno-
types, the analysis of the effect at the codon 10 genotype on 
the development of ALC may not be correct. Therefore, the 
amount of alcohol consumption according to each genotype 
was analyzed, and it was not different. This implies that the 
analysis was performed in the equal condition in regard to 
the amount of alcohol consumption. In such condition, the 
genotype at codon 10 could not exert effects on the develop-
ment of ALC. 
It has been reported that TGF-β1 is also associated with 
the development of HCC.
14,19,32 The L/L genotype at codon 
10 is associated with the development of HCC in compar-
ison with other genotypes.
22,32 In this study, 24 patients with 
HCC who have underlying cirrhosis were included. It may 
influence on the analysis of the genotypes at codon 10 for 
the development of cirrhosis. Therefore, the subgroup analy-
sis of the genetic polymorphism at codon 10 was performed 
on 158 ALC patients excluding HCC. Nonetheless, the re-
sult of 158 ALC patients was not different from that of the 
control group (data was not shown).
This study has several limitations. First, there is an in-
accuracy in estimating the amount of alcohol consumption. 
It was determined by interviewing with patients or family 
members. This method may measure the amount of alcohol 
consumption inaccurately due to the bias of information or 
the bias of memory.
33 Although this study adjusted the bias 
of the amount of alcohol consumption by categorizing alco-
hol dose, there will be the possibility of erroneous information 
still. Second, cirrhosis was diagnosed by endoscopy or 
imaging methods. The liver biopsy is the most accurate tool 
for the diagnosis of liver cirrhosis. However, it takes only a 
small portion of liver, and thus it dose not represent the path-
ology of the entire liver. Furthermore, it may be fatal in 
decompensated cirrhotic patients. To compensate clinical 
diagnosis of cirrhosis, the subgroup analysis was done for 
comparing the genetic polymorphism at codon 10 between 
patients with advanced cirrhosis (Child-Pugh class B or C) 
and the control group. Nevertheless, the analysis also did not 
show differences. Third, if drinkers with significant alcohol 
consumption but without liver cirrhosis were recruited as the 
control group, more accurate effects of the genotype at 
codon 10 on the development of cirrhosis could be examined. 
However, those drinkers could not be recruited. Fourth, the 
number of the control group was not large, and thus they 
may not represent the genotype at codon 10 in the entire 
Koreans. However, the distribution of the genotype in the 
healthy controls in Asia including Korea was not greatly 
different from the distribution of the genotype in this study.
14-16
In conclusion, the polymorphism at the codon 10 in TGF-
β1 gene has no effect on the development of ALC. Further 
studies comparing with the habitual drinking group without 
alcoholic cirrhosis are required. In addition, studies on other 
genetic factors associated with the development of ALC are 
also needed.
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